FNY Partners Fund’s Endologix Inc ELGX Stock Holding History

FNY Partners Fund’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10	Closed	–	–	1374
2017 Q1	$0	Buy	+10	New	+$661	﹤0.01%	1573

Other funds holding ELGX

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

FNY Partners Fund's ELGX Position: Q2 2017 in Review

FNY Partners Fund sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 10 shares.

FNY Partners Fund first reported a position in ELGX in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

FNY Partners Fund reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 10 Endologix Inc shares in Q2 2017.
FNY Partners Fund first reported a position in Endologix Inc in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Endologix Inc position peaked at $0 in Q1 2017.
111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.